Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 339

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia

Open access
Klco, Jeffery M., Miller, Christopher A., Griffith, Malachi, Petti, Allegra, Spencer, David H., Ketkar-Kulkarni, Shamika, Wartman, Lukas D., Christopher, Matthew, Lamprecht, Tamara L., Helton, Nicole M., Duncavage, Eric J., Payton, Jacqueline E., Baty, Jack, Heath, Sharon E., Griffith, Obi L., Shen, Dong, Hundal, Jasreet, Chang, Gue Su, Fulton, Robert, O'Laughlin, Michelle, Fronick, Catrina, Magrini, Vincent, Demeter, Ryan T., Larson, David E., Kulkarni, Shashikant, Ozenberger, Bradley A., Welch, John S., Walter, Matthew J., Graubert, Timothy A., Westervelt, Peter, Radich, Jerald P., Link, Daniel C., Mardis, Elaine R., DiPersio, John F., Wilson, Richard K., Ley, Timothy J.·2015·JAMA

Abstract

IMPORTANCE: Tests that predict outcomes for patients with acute myeloid leukemia (AML) are imprecise, especially for those with intermediate risk AML. OBJECTIVES: To determine whether genomic approaches can provide novel prognostic information for adult patients with de novo AML. DESIGN, SETTING, AND PARTICIPANTS: Whole-genome or exome sequencing was performed on samples obtained at disease presentation from 71 patients with AML (mean age, 50.8 years) treated with standard induction chemotherapy at a single site starting in March 2002, with follow-up through January 2015. In addition, deep digital sequencing was performed on paired diagnosis and remission samples from 50 patients (including 32 with intermediate-risk AML), approximately 30 days after successful induction therapy. Twenty-five of the 50 were from the cohort of 71 patients, and 25 were new, additional cases. EXPOSURES: Whole-genome or exome sequencing and targeted deep sequencing. Risk of identification based on genetic data. MAIN OUTCOMES AND MEASURES: Mutation patterns (including clearance of leukemia-associated variants after chemotherapy) and their association with event-free survival and overall survival. RESULTS: Analysis of comprehensive genomic data from the 71 patients did not improve outcome assessment over current standard-of-care metrics. In an analysis of 50 patients with both presentation and documented remission samples, 24 (48%) had persistent leukemia-associated mutations in at least 5% of bone marrow cells at remission. The 24 with persistent mutations had significantly reduced event-free and overall survival vs the 26 who cleared all mutations. Patients with intermediate cytogenetic risk profiles had similar findings. [table: see text]. CONCLUSIONS AND RELEVANCE: The detection of persistent leukemia-associated mutations in at least 5% of bone marrow cells in day 30 remission samples was associated with a significantly increased risk of relapse, and reduced overall survival. These data suggest that this genomic approach may improve risk stratification for patients with AML.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.2015.9643

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 339

Metadata

Authors
Klco, J. M., Miller, C. A., Griffith, M., Petti, A., Spencer, D. H., Ketkar-Kulkarni, S., Wartman, L. D., Christopher, M., Lamprecht, T. L., Helton, N. M., Duncavage, E. J., Payton, J. E., Baty, J., Heath, S. E., Griffith, O. L., Shen, D., Hundal, J., Chang, G. S., Fulton, R., O'Laughlin, M., Fronick, C., Magrini, V., Demeter, R. T., Larson, D. E., Kulkarni, S., Ozenberger, B. A., Welch, J. S., Walter, M. J., Graubert, T. A., Westervelt, P., Radich, J. P., Link, D. C., Mardis, E. R., DiPersio, J. F., Wilson, R. K., & Ley, T. J.
Venue
JAMA
Published
2015-08-25
Volume
314
Issue
8
Pages
811
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W1920829940
Cited by
339
References
29
FWCI
33.69
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia. https://app.cochat.ai/papers/10.1001/jama.2015.9643
The paper
Klco, J. M., Miller, C. A., Griffith, M., Petti, A., Spencer, D. H., Ketkar-Kulkarni, S., Wartman, L. D., Christopher, M., Lamprecht, T. L., Helton, N. M., Duncavage, E. J., Payton, J. E., Baty, J., Heath, S. E., Griffith, O. L., Shen, D., Hundal, J., Chang, G. S., Fulton, R., . . . Ley, T. J. (2015). Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia. JAMA. https://doi.org/10.1001/jama.2015.9643

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.